Literature DB >> 24469729

Conditioned medium enhances the fusion capability of rat bone marrow mesenchymal stem cells and cardiomyocytes.

Kanwal Haneef1, Nadia Naeem, Irfan Khan, Hana'a Iqbal, Nurul Kabir, Siddiqua Jamall, Muniza Zahid, Asmat Salim.   

Abstract

Mesenchymal stem cells (MSCs) show accelerated regeneration potential when these cells experience hypoxic stress. This "preconditioning" has shown promising results with respect to cardio-protection as it stimulates endogenous mechanisms resulting in multiple cellular responses. The current study was carried out to analyze the effect of hypoxia on the expression of certain growth factors in rat MSCs and cardiomyocytes (CMs). Both cell types were cultured and assessed separately for their responsiveness to hypoxia by an optimized dose of 2,4,-dinitrophenol (DNP). These cells were allowed to propagate under normal condition for either 2 or 24 h and then analyzed for the expression of growth factors by RT-PCR. Variable patterns of expression were observed which indicate that their expression depends on the time of re-oxygenation and extent of hypoxia. To see whether the growth factors released during hypoxia affect the fusion of MSCs with CMs, we performed co-culture studies in normal and conditioned medium. The conditioned medium is defined as the medium in which CMs were grown for re-oxygenation till the specified time period of either 2 or 24 h after hypoxia induction. The results showed that the fusion efficiency of cells was increased when the conditioned medium was used as compared to that in the normal medium. This may be due to the presence of certain growth factors released by the cells under hypoxic condition that promote cell survival and enhance their fusion or regenerating ability. This study would serve as another attempt in designing a therapeutic strategy in which conditioned MSCs can be used for ischemic diseases and provide more specific therapy for cardiac regeneration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469729     DOI: 10.1007/s11033-014-3170-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

1.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

Review 2.  Potential of stem-cell-based therapies for heart disease.

Authors:  Deepak Srivastava; Kathryn N Ivey
Journal:  Nature       Date:  2006-06-29       Impact factor: 49.962

3.  An improved protocol for primary culture of cardiomyocyte from neonatal mice.

Authors:  P Sreejit; Suresh Kumar; Rama S Verma
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-02-23       Impact factor: 2.416

Review 4.  Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy.

Authors:  Hironori Nakagami; Ryuichi Morishita; Kazuhisa Maeda; Yasushi Kikuchi; Toshio Ogihara; Yasufumi Kaneda
Journal:  J Atheroscler Thromb       Date:  2006-04       Impact factor: 4.928

5.  Stem cells--clinical application and perspectives.

Authors:  Michael Brehm; Tobias Zeus; Bodo Eckehard Strauer
Journal:  Herz       Date:  2002-11       Impact factor: 1.443

6.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

7.  Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections.

Authors:  Attila Cselenyák; Eszter Pankotai; Eszter M Horváth; Levente Kiss; Zsombor Lacza
Journal:  BMC Cell Biol       Date:  2010-04-20       Impact factor: 4.241

8.  Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.

Authors:  Peter Kanellakis; Nicholas J Slater; Xiao-Jun Du; Alex Bobik; David J Curtis
Journal:  Cardiovasc Res       Date:  2006-02-23       Impact factor: 10.787

Review 9.  Hypoxia and stem cell-based engineering of mesenchymal tissues.

Authors:  Teng Ma; Warren L Grayson; Mirjam Fröhlich; Gordana Vunjak-Novakovic
Journal:  Biotechnol Prog       Date:  2009 Jan-Feb

10.  MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell.

Authors:  J Xu; X Liu; Y Jiang; L Chu; H Hao; Z Liua; C Verfaillie; J Zweier; K Gupta; Z Liu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more
  3 in total

1.  Hypoxic stress and IL-7 gene overexpression enhance the fusion potential of rat bone marrow mesenchymal stem cells with bovine renal epithelial cells.

Authors:  Rakhshinda Habib; Kanwal Haneef; Nadia Naeem; Irfan Khan; Siddiqua Jamall; Asmat Salim
Journal:  Mol Cell Biochem       Date:  2015-02-10       Impact factor: 3.396

Review 2.  In vitro cardiac tissue models: Current status and future prospects.

Authors:  Anurag Mathur; Zhen Ma; Peter Loskill; Shaheen Jeeawoody; Kevin E Healy
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

Review 3.  Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine.

Authors:  Agata Nowak-Stępniowska; Paulina Natalia Osuchowska; Henryk Fiedorowicz; Elżbieta Anna Trafny
Journal:  Stem Cells Int       Date:  2022-03-26       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.